SMCL NGS Hub, Olink Certified Service Provider, is pleased to announce an upcoming presentation at the Cambridge Biomedical Campus featuring the launch of the new Olink Target Neurodegeneration Panel in the T48 format, offering absolute quantification. Dr Parham Ashrafzadeh, Business Development Manager at Olink Proteomics, will introduce the panel and discuss its relevance and applications in neurodegenerative research.
There will be opportunities for 1-to-1 conversations to implement new projects, interactive Q&A, networking and refreshments.
All are welcome to attend, with particular interest for research groups working in the field.
Registration: New Era in Neurodegeneration Research — Olink®